×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [office of blood research]
Managing Acute HIV Infection Nucleic Acid Amplification Testing January 26, 2009 Nick Curry, MD, MPH Infectious Diseases Prevention Section Texas Department
215 views
Concurrent and Component Plasma: CBER Considerations on Standards and Labeling BPAC April 28, 2011 Mark Weinstein, Ph.D. Office of Blood Research and Review
262 views
FDA Hot Topics Alan E. Williams, Ph.D. Office of Blood Research and Review, CBER, FDA Pharma Conference January 27-29, 2010
216 views
CBER Introduction to Regulation Robert A. Yetter Associate Director for Review Management Center for Biologics Evaluation and Research
225 views
BIOVIGILANCE IN THE UNITED STATES: EFFORTS TO BRIDGE A CRITICAL GAP IN PATIENT SAFETY AND DONOR HEALTH Alan E. Williams, Ph.D. Office of Blood Research
221 views
Experimental Clearance of TSE Infectivity in Plasma-derived FVIII Products
25 views
Vaccine-Derived Poliovirus Infections Minnesota, 2005 Jim Alexander & Jane Seward National Vaccine Advisory Committee Washington, DC February 8, 2006
215 views
Managing Acute HIV Infection Nucleic Acid Amplification Testing January 26, 2009 Nick Curry, MD, MPH Infectious Diseases Prevention Section Texas Department
217 views
Office of Blood Research and Review Site Visit for Research
37 views
Office of Blood Research and Review Overview of Research Jay S. Epstein, M.D. Director, OBRR, CBER Blood Products Advisory Committee Meeting March 10,
225 views
Office of Blood Research and Review Overview of Research
37 views